Development of
scientific and technological cooperation between Iran and Jordan was emphasized
in a meeting between Ali Morteza Birang, deputy for
international affairs and technological exchange, and Dr. Al-rabiei, director
general of the pharmaceutical department of the ministry of health of Oman.

According to the information center of national elites foundation,  Ali Morteza Birang, deputy for international affairs and
technological exchange and head of the international science and technology
interactions, had a meeting with Dr. Al-rabiei, director
general of the pharmaceutical department of the ministry of health of Oman, in
which a report on the recent activities of the Vice-Presidency in the area of
science and technology development, asserting: one of the priorities of the
Vice-Presidency in the past years has been the support and development of
knowledge-based companies.

However,
other tasks followed up by the Vice-Presidency include the development of
accelerators, innovation centers and support of development of international
businesses of knowledge-based companies.

He
continued: over the past five years, constructive interactions have been made
between Iran and Oman in various areas of science and technology, and
cooperative operational models are defined by the research council of Oman.

Birang
also expressed: the geographical, cultural and political ties between the two
countries have provided us and Omani parties with an opportunity to make deeper
and more effective bonds between research centers and active private sector in
the area of technology by proper policies. Inviting the research companies and
institutes of both countries for visit of the technological infrastructures of
Iran and Oman would be an effective step in this regard.

During
this meeting, Dr. Al-Rabiei appreciated being invited to participate in visit
of technological achievements of Iran in the area of health, regarding it as an
opportunity for development of technological cooperation between Iran and Oman.
He also mentioned the primary agreements on facilitation of registering and
marketing of drugs and biological products of Iran in Oman, considering the
benefits of being present in the Omani market and re-export from this country
to other regional countries.

In
addition, the science and technology delegation of Oman visited Pardis
Technology Park and CinnaGen during this travel.